BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35628462)

  • 1. Association between Decreased ITGA7 Levels and Increased Muscle α-Synuclein in an MPTP-Induced Mouse Model of Parkinson's Disease.
    Han S; Lim S; Yeo S
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in
    Han S; Seo MH; Lim S; Yeo S
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
    Seo MH; Yeo S
    Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between SGK1 and α-synuclein in skeletal muscle in an MPTP-induced Parkinson's disease model.
    Heo EJ; Lee Y; Hyung Seo M; Yeo S
    Neurosci Lett; 2023 Sep; 814():137464. PubMed ID: 37634811
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Seo MH; Yeo S
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acupuncture Inhibits the Increase in Alpha-Synuclein in Substantia Nigra in an MPTP- Induced Parkinsonism Mouse Model.
    Yeo S; Song J; Lim S
    Adv Exp Med Biol; 2020; 1232():401-408. PubMed ID: 31893437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringenin Decreases α-Synuclein Expression and Neuroinflammation in MPTP-Induced Parkinson's Disease Model in Mice.
    Mani S; Sekar S; Barathidasan R; Manivasagam T; Thenmozhi AJ; Sevanan M; Chidambaram SB; Essa MM; Guillemin GJ; Sakharkar MK
    Neurotox Res; 2018 Apr; 33(3):656-670. PubMed ID: 29427283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
    Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
    Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
    Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
    Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease.
    Mariucci G; Pagiotti R; Galli F; Romani L; Conte C
    J Mol Neurosci; 2018 Apr; 64(4):611-618. PubMed ID: 29589201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acupuncture Inhibits the Increase in Alpha-Synuclein by Modulating SGK1 in an MPTP Induced Parkinsonism Mouse Model.
    Yeo S; Lim S
    Am J Chin Med; 2019; 47(3):527-539. PubMed ID: 30966771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroprotective effect of cinnamaldehyde in MPTP-induced mouse model of subacute Parkinson's disease].
    Wu SH; Shi YJ; An YF; Zhao DD; Li HB; Li GL
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(23):6485-6493. PubMed ID: 36604895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7,8-dihydroxyflavone Ameliorates Motor Deficits Via Suppressing α-synuclein Expression and Oxidative Stress in the MPTP-induced Mouse Model of Parkinson's Disease.
    Li XH; Dai CF; Chen L; Zhou WT; Han HL; Dong ZF
    CNS Neurosci Ther; 2016 Jul; 22(7):617-24. PubMed ID: 27079181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein Expression Is Preserved in Substantia Nigra GABAergic Fibers of Young and Aged Neurotoxin-Treated Rhesus Monkeys.
    Vermilyea SC; Guthrie S; Hernandez I; Bondarenko V; Emborg ME
    Cell Transplant; 2019 Apr; 28(4):379-387. PubMed ID: 30857404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Involvement of Progranulin for α-Synuclein Reduction through Autolysosome Formation.
    Fujimori H; Ohba T; Nakamura S; Shimazawa M; Hara H
    Biol Pharm Bull; 2023; 46(8):1032-1040. PubMed ID: 37532554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated α-Synuclein Accumulations and Lewy Body-like Pathology Distributed in Parkinson's Disease-Related Brain Areas of Aged Rhesus Monkeys Treated with MPTP.
    Huang B; Wu S; Wang Z; Ge L; Rizak JD; Wu J; Li J; Xu L; Lv L; Yin Y; Hu X; Li H
    Neuroscience; 2018 May; 379():302-315. PubMed ID: 29592843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treadmill exercise alleviates motor deficits and improves mitochondrial import machinery in an MPTP-induced mouse model of Parkinson's disease.
    Koo JH; Cho JY; Lee UB
    Exp Gerontol; 2017 Mar; 89():20-29. PubMed ID: 28062370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson's Disease.
    Duperrier S; Bortolozzi A; Sgambato V
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of m6A modification regulators in the substantia nigra and striatum of MPTP-induced Parkinson's disease mice.
    Yu Z; Huang L; Xia Y; Cheng S; Yang C; Chen C; Zou Z; Wang X; Tian X; Jiang X; Zhou L
    Neurosci Lett; 2022 Nov; 791():136907. PubMed ID: 36209975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.